Are women and minorities adequately represented in new drug testing?

November 7, 2017, Mary Ann Liebert, Inc
Credit: Mary Ann Liebert, Inc., publishers

A new study to assess the effects of U.S. Food and Drug Administration (FDA) regulations and guidance, intended to encourage greater inclusion of women and minorities in clinical drug trials, has shown appropriate levels of female participation based on the estimated sex ratio of people affected by a particular disease. In contrast, some racial minorities, and especially African Americans, remain under-represented in most drug development programs, according to the study published in Journal of Women's Health.

Emmanuel Fadiran, PhD and colleagues from the Center for Drug Evaluation and Research (CDER), and the Office of Women's Health, Office of the Commissioner of the FDA examined the demographic make-up of clinical trial participants and whether efficacy and safety data were obtained for both men and women for new drugs approved between 2013-2015 by CDER. To assess sex-based representation in drug efficacy and safety testing, the researchers determined the ratio of the proportion of women in clinical trials for a particular disease population relative to the estimated proportion of women in the disease population (PPR) for a new drug indication.

The authors reported that sex-based analyses for both efficacy and safety were conducted for the majority of new drug applications during the study period. Furthermore, representation of women in was appropriate for more when the estimated disease prevalence by sex (PPR) was considered. These findings are presented in the article entitled "Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015".

"The results presented by Fadiran et al. help to reassure us that are being included at an appropriate level in all phases of clinical drug studies. However, it will be important going forward to remain vigilant to the potential for sex-based disparities in new drug development, and to address the ongoing under-representation of some , especially when they may have a relatively high prevalence for a particular indication," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.

Explore further: Safety of medical devices not often evaluated by sex, age, or race

More information: Alice Chen et al, Representation of Women and Minorities in Clinical Trials for New Molecular Entities and Original Therapeutic Biologics Approved by FDA CDER from 2013 to 2015, Journal of Women's Health (2017). DOI: 10.1089/jwh.2016.6272

Related Stories

Safety of medical devices not often evaluated by sex, age, or race

July 25, 2017
Researchers at Yale and the University of California-San Francisco have found that few medical devices are analyzed to consider the influence of their users' sex, age, or race on safety and effectiveness.

Applying research advances to improve cardiovascular health in women

September 26, 2017
Cardiovascular disease remains the main cause of death among women, but evidence-based advances are enhancing clinical care in seven key areas, improving the lives of women living with and at risk for heart disease. A review ...

Are there gender differences in anti-HIV drug efficacy?

August 9, 2012
Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration (FDA) has ...

Women of color: What we know and don't know about their unique health challenges

April 15, 2016
Women of color face both racial and gender disparities in the incidence, onset, and outcomes of diseases as diverse as cancer, cardiovascular disease, HIV infection and age-related disability. The unique health challenges ...

Can sexual risk and behaviors among women help explain HIV disparities by race/ethnicity?

July 13, 2017
Researchers examined the sexual behaviors of a nationally representative group of U.S. women that can prevent against or increase risk for HIV infection and reported the differences in behaviors such as condom use and concurrent ...

Improved safety and efficacy among women who switched from a multi-pill antiretroviral drug regimen

September 21, 2015
Results from the first phase 3 HIV study to enroll only women show improved safety and efficacy of the drug Stribild over multi-pill antiretroviral drug regimens. The research was presented at ASM's 55th Interscience Conference ...

Recommended for you

Hot cars can hit deadly temperatures in as little as one hour

May 24, 2018
A lot can happen at 160 degrees Fahrenheit: Eggs fry, salmonella bacteria dies, and human skin will suffer third-degree burns. If a car is parked in the sun on a hot summer day, its dashboard can hit 160 degrees in about ...

Research finds a little exercise does a lot of good for ageing muscles

May 24, 2018
Getting old doesn't necessarily mean getting weak and frail – just a little bit of exercise can help maintain muscle mass and strength, Otago research has revealed.

In helping smokers quit, cash is king, e-cigarettes strike out

May 23, 2018
Free smoking cessation aids, such as nicotine patches and chewing gum, are a staple of many corporate wellness programs aimed at encouraging employees to kick the habit. But, new research shows that merely offering such aids ...

What makes us well? Diversity, health care, and public transit matter

May 23, 2018
Diverse neighbors. Health centers. Commuter trains. These community attributes, and other key factors, are linked to well-being and quality of life, according to Yale researchers.

Time spent sitting at a screen matters less if you are fit and strong

May 23, 2018
The impact of screen time on cardiovascular disease, cancer incidence and mortality may be greatest in people who have lower levels of grip-strength, fitness and physical activity, according to a study published in the open ...

Widely used e-cigarette flavoring impairs lung function

May 23, 2018
A new study has found that a common e-cigarette flavoring that has chemical characteristics similar to toxic chemicals found in cigarette smoke disrupts an important mechanism of the lungs' antibacterial defense system. The ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.